Revvity’s AutoDELFIA^® immunoassay system is the most widely used platform for Down syndrome screening, now available also for pre-eclampsia screening. Fully automatic and easy to use, AutoDELFIA has become the screening solution of choice for laboratories around the world and giving reliable, high quality results both for aneuploidy and pre-eclampsia risk assessment during pregnancy.

Now Revvity is proud to introduce the new AutoDELFIA system. By making AutoDELFIA even more effective and easier to use, we give you a clear reason to change your screening for the better. We offer FMF approved assays with high performance and long term precision.

AutoDELFIA is a fully automatic system for sensitive and reproducible quantitation of analytes commonly used in prenatal screening programs. The instrument is supported by the widest available range of prenatal analytes available on any platform. All kits employ the sensitive and robust DELFIA^® chemistry, based on time-resolved fluorescence. Every assay stage from sample dispensing to measurement is performed automatically. Analytical results are easy to manage and transfer to risk calculation software such as LifeCycle.